His scientific interests lie mostly in Virology, Immunology, Coronavirus, Virus and Viral load. His Virology study combines topics in areas such as Infection control, Pneumonia, Histiocyte, Fibroblast and Betacoronavirus. His research integrates issues of Transmission and Middle East respiratory syndrome in his study of Infection control.
His Coronavirus research includes elements of Antibody, Epidemiology, Coronaviridae and Pneumonia. His Viral load study combines topics from a wide range of disciplines, such as Vero cell, Viral culture and Internal medicine, Saliva, Respiratory system. His Internal medicine study incorporates themes from Gastroenterology and Antibacterial agent.
Vincent C.C. Cheng focuses on Virology, Microbiology, Infection control, Internal medicine and Immunology. His Virology study integrates concerns from other disciplines, such as Pandemic, Coronavirus and Severe acute respiratory syndrome coronavirus 2. His Coronavirus research includes themes of Betacoronavirus and Pneumonia.
His Infection control research incorporates elements of Transmission, Outbreak, Hygiene and Emergency medicine. His biological study spans a wide range of topics, including Asymptomatic and Epidemiology. The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine.
Coronavirus disease 2019, Virology, Infection control, Severe acute respiratory syndrome coronavirus 2 and Outbreak are his primary areas of study. His Virology study incorporates themes from Genome, Gene and Serology. The Infection control study combines topics in areas such as Transmission, Pandemic, Coronavirus and Environmental health.
Vincent C.C. Cheng interconnects Viral culture, Lineage, Real-time polymerase chain reaction and Saliva in the investigation of issues within Severe acute respiratory syndrome coronavirus 2. His Saliva research is multidisciplinary, incorporating elements of Gastroenterology and Viral load. His Outbreak research includes elements of Asymptomatic, Epidemiology, Emergency medicine and Pneumonia.
Vincent C.C. Cheng spends much of his time researching Viral load, Internal medicine, Coronavirus, Virology and Pneumonia. His research combines Infection control and Viral load. His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Point of care and Titer and other disciplines.
His research in Coronavirus tackles topics such as Surgical mask which are related to areas like Respiratory tract, Viral nucleocapsid, Airborne transmission and Hamster. His study looks at the intersection of Virology and topics like Genome with Stop codon, Vaccination and Real-time polymerase chain reaction. His study in Pneumonia is interdisciplinary in nature, drawing from both Epidemiology, Outbreak, Contact tracing, Asymptomatic and Betacoronavirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.
Jasper Fuk Woo Chan;Shuofeng Yuan;Kin Hang Kok;Kelvin Kai Wang To;Kelvin Kai Wang To.
The Lancet (2020)
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
Kelvin Kai Wang To;Owen Tak Yin Tsang;Wai Shing Leung;Anthony Raymond Tam.
Lancet Infectious Diseases (2020)
Consistent Detection of 2019 Novel Coronavirus in Saliva.
Kelvin Kai Wang To;Kelvin Kai Wang To;Kelvin Kai Wang To;Owen Tak Yin Tsang;Cyril Chik-Yan Yip;Cyril Chik-Yan Yip;Kwok Hung Chan.
Clinical Infectious Diseases (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Ivan Fan Ngai Hung;Kwok Cheung Lung;Eugene Yuk Keung Tso;Raymond Liu.
The Lancet (2020)
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
Vincent C. C. Cheng;Susanna K. P. Lau;Patrick C. Y. Woo;Kwok Yung Yuen.
Clinical Microbiology Reviews (2007)
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
Jasper F. W. Chan;Susanna K. P. Lau;Kelvin K. W. To;Vincent C. C. Cheng.
Clinical Microbiology Reviews (2015)
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens.
Jasper Fuk-Woo Chan;Cyril Chik-Yan Yip;Kelvin Kai-Wang To;Tommy Hing-Cheung Tang.
Journal of Clinical Microbiology (2020)
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Adarsh Bhimraj;Rebecca L. Morgan;Amy Hirsch Shumaker;Valery Lavergne.
Clinical Infectious Diseases (2020)
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.
F Chen;K.H Chan;Y Jiang;R.Y.T Kao.
Journal of Clinical Virology (2004)
Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection
Kelvin K. W. To;Ivan F. N. Hung;Iris W. S. Li;Kar-Lung Lee.
Clinical Infectious Diseases (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: